GlassScriptPhysician profile
James R Mackenzie
NPI 1043260102
$864.14
in general payments reported to CMS, 2019-2025
10 companies · $180 in 2025
The $180 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $192 · 2020: $50.22 · 2021: $14.00 · 2022: $75.85 · 2023: $257 · 2024: $93.90 · 2025: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $532.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $531.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $290.66 | 2022-2025 | |
| Piramal Critical Care | $203.76 | 2019-2025 | |
| Allergan, INC. | $124.60 | 2019-2022 | |
| Stryker Corporation | $78.32 | 2023-2025 | Spinejack, Mild Device Kit |
| Si-Bone, INC. | $62.79 | 2019-2023 | |
| Pfizer INC. | $31.92 | 2019 | |
| Bioventus LLC | $24.26 | 2019 | |
| Medtronic USA, INC. | $18.05 | 2020 | |
| Novartis Pharmaceuticals Corporation | $16.72 | 2019 | |
| Abbott Laboratories | $13.06 | 2023 | Proclaim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Mackenzie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.